Financial Statements — CIG-C
Balance Sheet
(in billions BRL)| Metric | FY
2024 | FY
2023 | FY
2022 | FY
2021 | FY
2020 | FY
2019 |
|---|
| Cash & Equivalents | 1.90 | 1.54 | 1.44 | 0.83 | 1.68 | 0.54 |
| Inventory | -- | -- | -- | -- | -- | 0.04 |
| Total Current Assets | 12.23 | 11.87 | 13.47 | 12.95 | 15.46 | 10.14 |
| Goodwill | -- | 0.01 | -- | -- | -- | -- |
| Total Non-current Assets* | 47.50 | 43.13 | 40.21 | 39.10 | 2.43 | 39.79 |
| Total Assets | 59.73 | 55.00 | 53.67 | 52.05 | 54.08 | 49.93 |
| Total Current Liabilities | 14.15 | 13.09 | 11.20 | 10.69 | 9.69 | 7.91 |
| Total Non-current Liabilities | 18.20 | 17.25 | 20.68 | 21.90 | 26.92 | 26.12 |
| Total Liabilities | 32.34 | 30.34 | 31.89 | 32.58 | 36.60 | 34.03 |
| Retained Earnings | 13.58 | 13.04 | 10.40 | 10.95 | -- | 8.75 |
| Total Stockholder Equity | 27.38 | 24.66 | 21.78 | 19.46 | 17.48 | 15.89 |
* Derived from reported values
Income Statement
(in billions BRL)| Metric | FY
2024 | FY
2023 | FY
2022 | FY
2021 | FY
2020 | FY
2019 |
|---|
| Total Revenue | 39.82 | 36.85 | 34.46 | 33.65 | 25.23 | 25.39 |
| Cost of Revenue* | 31.66 | 28.47 | 27.65 | 26.92 | 19.85 | 19.60 |
| Gross Profit | 8.16 | 8.38 | 6.81 | 6.72 | 5.38 | 5.79 |
| Research & Development | 0.00 | 0.01 | -- | -- | 0.23 | 0.20 |
| Selling, General & Admin | 0.82 | -- | -- | -- | -- | -- |
| Total Operating Expenses | 8.19 | -- | -- | -- | 1.59 | 2.88 |
| Pretax Income | 9.36 | 6.85 | 4.12 | 4.70 | 3.80 | 4.47 |
| Tax Provision | 2.24 | 1.08 | (0.03) | (0.95) | 0.94 | 1.57 |
| Net Income | 7.12 | 5.77 | 4.09 | 3.75 | 2.87 | 3.13 |
* Derived from reported values
Cash Flow Statement
(in billions BRL)| Metric | FY
2024 | FY
2023 | FY
2022 | FY
2021 | FY
2020 | FY
2019 |
|---|
| Operating Cash Flow | 5.50 | 6.65 | 6.61 | -- | 8.61 | 2.04 |
| Investing Cash Flow | (2.38) | (3.97) | (3.20) | 1.37 | (5.08) | (1.19) |
| Financing Cash Flow | (2.76) | (2.58) | (2.79) | (5.91) | (2.39) | (1.20) |
